Current Position:
Research Associate at Intas PharmaceuticalsExperience:
7 yearsLocation:
Kolkata, West Bengal, IndiaJul 2024 - Current
Jul 2023 - Jun 2024
Jan 2023 - Jun 2023
Jul 2018 - Jun 2023
May 2022 - Jun 2022
Oct 2021 - Oct 2021
Jul 2021 - Oct 2021
Jul 2021 - Oct 2021
Sep 2021 - Sep 2021
Aug 2021 - Sep 2021
Aug 2021 - Aug 2021
Jul 2021 - Jul 2021
Jun 2021 - Aug 2021
Jul 2021 - Jul 2021
Apr 2021 - May 2021
Jan 2021 - Mar 2021
M.Tech at KIIT School of Biotechnology
ICSE (X) & ISC (XII) at St. Thomas' Boys' School, Kidderpore, Kolkata-700023
Name: Intas Pharmaceuticals
Speciality: Biosimilars Development, Recombinant Proteins Manufacturing, Central Nervous System, Cardio-Diabeto, Plasma Products, Women's Health, Animal Health, Chronic Therapies, Pharmaceuticals, Research and Development, Oncology, Animal Health, Gastroenterology, Urology, Auto immune, Rheumatology, Nephrology, Generic medicine, NDDS products, Hormone based therapies
Location: Ahmedabad, Gujarat, India
Employees: 10000+
Description: Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which ...
What is Vivek Shukla's average duration of employment for different companies?
On average, Vivek Shukla works for one company for 6 monthsWhat industries has Vivek Shukla worked in?
Vivek Shukla works in the Pharmaceuticals. Previously, Vivek Shukla worked in the Education Management, and Biotechnology, and E-Learning, and International Affairs.What positions has Vivek Shukla held before?
Previously, Vivek Shukla worked as a Trainee Research Associate, and Dissertation Trainee, and Student, and Project Intern, and Worshop.How do I contact Vivek Shukla?
Vivek Shukla's email address is s**********k@intaspharma.com, phone number is +91-***-***-3414. Sign up to get contact details.Who are Vivek Shukla's peers at other companies?
Vivek Shukla's peers at other companies are Lakmini De Silva and Peter Oviroh and Adedeji AdeniranFind email for 850M+ professionals